StockData
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT) stock

VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)

Close on Nov 17, 2026Market cap $68.37MP/E –Yield –

vTv Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

vTv Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -25.1%. For fiscal 2024 it was -2377.6%, against -1116.9% the year before. The highest annual figure on record is -159.4% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-2377.6%−1260.6
FY2022Dec 31, 2022-1116.9%−576.1
FY2021Dec 31, 2021-540.9%−356.1
FY2020Dec 31, 2020-184.8%+571.1
FY2019Dec 31, 2019-755.9%−596.4
FY2018Dec 31, 2018-159.4%+17257.1
FY2017Dec 31, 2017-17416.5%−8738.3
FY2016Dec 31, 2016-8678.2%−1329.1
FY2015Dec 31, 2015-7349.1%−5483.6
FY2014Dec 31, 2014-1865.5%+1805.9
FY2013Dec 31, 2013-3671.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 202663.1%+44807.6
Q4 FY2024Dec 31, 2024-28776.5%−28452.4
Q1 FY2024Mar 31, 2024-562.7%+122870.6
Q4 FY2022Dec 31, 2022-70477.8%−70424.3
Q2 FY2022Jun 30, 2022-44744.4%+7144.4
Q1 FY2022Mar 31, 2022-324.1%+109.6
Q4 FY2021Dec 31, 2021-123433.3%−123461.9
Q3 FY2021Sep 30, 2021-53.4%+40403.7
Q2 FY2021Jun 30, 2021-51888.9%+31186.1
Q1 FY2021Mar 31, 2021-433.6%+90823.5
Q4 FY2020Dec 31, 202028.6%+67841.1
Q3 FY2020Sep 30, 2020-40457.1%−40195.0
Q1 FY2020Mar 31, 2020-83075.0%−82609.5
Q4 FY2019Dec 31, 2019-91257.1%−91249.4
Q3 FY2019Sep 30, 2019-67812.5%−67768.6
Q2 FY2019Jun 30, 2019-262.1%+96.0
Q1 FY2019Mar 31, 2019-465.5%−22.9
Q4 FY2018Dec 31, 2018-7.8%+5473.8
Q3 FY2018Sep 30, 2018-43.9%+76896.1
Q2 FY2018Jun 30, 2018-358.2%+96680.3
Q1 FY2018Mar 31, 2018-442.5%+45404.1
Q4 FY2017Dec 31, 2017-5481.5%+29552.7
Q3 FY2017Sep 30, 2017-76940.0%−41340.0
Q2 FY2017Jun 30, 2017-97038.5%–
Q1 FY2017Mar 31, 2017-45846.7%–
Q4 FY2016Dec 31, 2016-35034.2%–
Q3 FY2016Sep 30, 2016-35600.0%–

More vTv Therapeutics figures

See a number that looks wrong?